Am J Perinatol 2021; 38(14): 1488-1493
DOI: 10.1055/s-0040-1713754
Original Article

Breastfeeding and Formula Selection in Neonatal Abstinence Syndrome

Amy L. Lembeck
1   Division of Neonatology, Department of Pediatrics, Einstein Medical Center Montgomery, CHOP Newborn Care Network, East Norriton, Pennsylvania
,
Deborah Tuttle
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
3   Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, Pennsylvania
,
Robert Locke
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
3   Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, Pennsylvania
,
Laura Lawler
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
,
Pamela Jimenez
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
,
Amy Mackley
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
,
David A. Paul
2   Department of Pediatrics, Christiana Care Health System, Newark, Delaware
3   Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, Pennsylvania
› Author Affiliations

Abstract

Objective This study aimed to determine if formula selection, low lactose versus standard term formula, has an effect on outcomes with a comparison to breastfed infants.

Study Design Retrospective cohort study of neonates ≥35 weeks gestation born with Neonatal Abstinence Syndrome (NAS) was conducted from July 2014 to November 2016. Primary outcomes included length of pharmacologic treatment (LOT), and length of stay (LOS), and weight change per day comparing term standard and low lactose formula majority feeding infants with secondary outcomes comparing breast fed majority feeding infants.

Results After investigating feeding methods for 249 NAS infants, a direct comparison of formula groups showed no differences in LOS (3, 95% confidence interval [CI]: −1.1 to 7 days), LOT (3.9, 95% CI: −0.4 to 8.1 days), or weight change per day (−2.4, 95% CI: −11.7 to 6.9 g/day). Breastfeeding improved LOT by 6.9 (95% CI: 3.4–10.5) and 10.8 days (95% CI: 5.9–15.6) and LOS by 7.4 (95% CI: 4.1–10.7) and 10.3 (95% CI: 5.8–14.9) days all reaching significance, in comparison to term and low lactose formula groups, respectively. Weight change per day was greater in the breast versus formula feeding groups when compared individually.

Conclusion We detected no benefit to low lactose formula in NAS infants. Breastfeeding is associated with clinical reduction in LOS and LOT but is associated with increased weight loss.

Key Points

  • Best formula choice for a neonatal abstinence syndrome (NAS) infant is unknown.

  • Many NAS moms cannot breastfeed.

  • Low lactose formula has no impact on NAS outcomes.



Publication History

Received: 14 December 2019

Accepted: 21 May 2020

Article published online:
30 June 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
  • 2 Hudak ML, Tan RC. Committee on Drugs; Committee on Fetus and Newborn; American Academy of Pediatrics. Neonatal drug withdrawal. Pediatrics 2012; 129 (02) e540-e560
  • 3 Maguire D. Care of the infant with neonatal abstinence syndrome: strength of the evidence. J Perinat Neonatal Nurs 2014; 28 (03) 204-211 , quiz E3–E4
  • 4 Casper T, Arbour M. Evidence-based nurse-driven interventions for the care of newborns with neonatal abstinence syndrome. Adv Neonatal Care 2014; 14 (06) 376-380
  • 5 Jansson LM. Academy of Breastfeeding Medicine Protocol Committee. ABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman. Breastfeed Med 2009; 4 (04) 225-228
  • 6 Müller MJ, Preuß C, Paul T, Streit F, Brandhorst G, Seeliger S. Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk. Breastfeed Med 2013; 8 (03) 327-329
  • 7 Eidelman AI. Breastfeeding and the use of human milk: an analysis of the American Academy of Pediatrics 2012 Breastfeeding Policy Statement. Breastfeed Med 2012; 7 (05) 323-324
  • 8 Bogen DL, Hanusa BH, Baker R, Medoff-Cooper B, Cohlan B. Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study. Hosp Pediatr 2018; 8 (01) 7-14
  • 9 Holmes AP, Schmidlin HN, Kurzum EN. Breastfeeding considerations for mothers of infants with neonatal abstinence syndrome. Pharmacotherapy 2017; 37 (07) 861-869
  • 10 Dryden C, Young D, Campbell N, Mactier H. Postnatal weight loss in substitute methadone-exposed infants: implications for the management of breast feeding. Arch Dis Child Fetal Neonatal Ed 2012; 97 (03) F214-F216
  • 11 Patrick SW, Kaplan HC, Passarella M, Davis MM, Lorch SA. Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011. J Perinatol 2014; 34 (11) 867-872
  • 12 Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006; 117 (06) e1163-e1169
  • 13 McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care 2011; 11 (04) 282-290
  • 14 Favara MT, Carola D, Jensen E. et al. Maternal breast milk feeding and length of treatment in infants with neonatal abstinence syndrome. J Perinatol 2019; 39 (06) 876-882
  • 15 Short VL, Gannon M, Abatemarco DJ. The association between breastfeeding and length of hospital stay among infants diagnosed with neonatal abstinence syndrome: a population-based study of in-hospital births. Breastfeed Med 2016; 11: 343-349
  • 16 McQueen K, Taylor C, Murphy-Oikonen J. Systematic review of newborn feeding method and outcomes related to neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2019; 48 (04) 398-407
  • 17 Hicks J, Morse E, Wyant DK. Barriers and facilitators of breastfeeding reported by postpartum women in methadone maintenance therapy. Breastfeed Med 2018; 13 (04) 259-265
  • 18 Seabrook JA, Biden CR, Campbell EE. Does the risk of exposure to marijuana outweigh the benefits of breastfeeding? A systematic review. Can J of Midwifery Research and Practice 2017; 2: 8-16
  • 19 McKnight S, Coo H, Davies G. et al. Rooming-in for infants at risk of neonatal abstinence syndrome. Am J Perinatol 2016; 33 (05) 495-501
  • 20 Howard MB, Schiff DM, Penwill N. et al. Impact of parental presence at infants' bedside on neonatal abstinence syndrome. Hosp Pediatr 2017; 7 (02) 63-69
  • 21 Newman A, Davies GA, Dow K. et al. Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital. Can Fam Physician 2015; 61 (12) e555-e561
  • 22 Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med 2010; 5 (04) 159-164
  • 23 Tolia VN, Patrick SW, Bennett MM. et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 2015; 372 (22) 2118-2126
  • 24 Brown RA, Dakkak H, Seabrook JA. Is breast best? Examining the effects of alcohol and cannabis use during lactation. J Neonatal Perinatal Med 2018; 11 (04) 345-356
  • 25 Dakkak H, Brown R, Twynstra J, Charbonneau K, Seabrook JA. The perception of pre- and post-natal marijuana exposure on health outcomes: a content analysis of Twitter messages. J Neonatal Perinatal Med 2018; 11 (04) 409-415
  • 26 Alsaleem M, Berkelhamer SK, Wilding GE, Miller LM, Reynolds AM. Effects of partially hydrolyzed formula on severity and outcomes of neonatal abstinence syndrome. Am J Perinatol 2019; 1: 212-217